Pro zobrazení tohoto obsahu je třeba být přihlášen.
Author Archives for m.popovic@wemakemedia.cz
DIFFERENTIAL DIAGNOSIS BETWEEN MYELODYSPLASTIC SYNDROMES AND NON-CLONAL CYTOPENIAS BY FLOW CYTOMETRY ANALYSIS USING A MYELOID MATURATION DATABASE
15 októbra, 2020 7:25 pm Leave your thoughtsAuthor(s): M Teresa Cedena, Fátima Mirás, Rosa M Ayala, et. al Abstract: P 661 Session topic: 9. Myelodysplastic...
UPDATED RESULTS FROM PHASE 2 STUDY OF GUADECITABINE FOR PATIENTS WITH UNTREATED INT-2/HIGH RISK MYELODYSPLASTIC SYNDROMES OR CHRONIC MYELOMONOCYTIC LEUKEMIA
15 októbra, 2020 7:25 pm Leave your thoughtsAuthor(s): Guillermo Montalban-Bravo, Prithviraj Bose, Yesid Alvarado, et. al. Abstract: P 315 Session topic: 10. Myelodysplastic syndromes –...
Myelodysplastický syndróm
15 októbra, 2020 7:25 pm Leave your thoughtsAbstrakt: Myelodysplastický syndróm (MDS) predstavuje skupinu klonálnych myeloidných ochorení, je charakterizovaný dysplastickými zmenami a inefektívnou hematopoézou, ktorá vedie k periférnej cytopénii so...
CHEMO-FREE TRIPLET COMBINATION OF TGR-1202, UBLITUXIMAB, AND IBRUTINIB IS WELL TOLERATED AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED CLL AND NHL
15 októbra, 2020 7:25 pm Leave your thoughtsAuthor(s): Loretta Nastoupil, Matthew A. Lunning, Julie M. Vose, et. al. Abstract: S 772 Session topic: 6. Chronic...
IBRUTINIB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA: UPDATED EFFICACY AND SAFETY OF THE RESONATE STUDY WITH UP TO FOUR YEARS OF FOLLOW-UP
15 októbra, 2020 7:25 pm Leave your thoughtsAuthor(s): Carol Moreno, John C. Byrd, Peter Hillmen, et. al. Abstract: S 769 Session topic: 6. Chronic lymphocytic...
BENDAMUSTINE (B), FOLLOWED BY OBINUTUZUMAB (G, GA101) AND VENETOCLAX (A, ABT-199) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): CLL2-BAG PHASE-II-TRIAL OF THE GERMAN CLL STUDY GROUP (GCLLSG)
15 októbra, 2020 7:25 pm Leave your thoughtsAuthor(s): Paula Cramer, Julia von Tresckow, Jasmin Bahlo, et. al. Abstract: S 464 Session topic: 6. Chronic lymphocytic...
IS FCR THE TREATMENT OF CHOICE FOR IGHV MUTATED CLL WITHOUT POOR FISH CYTOGENETICS?
15 októbra, 2020 7:25 pm Leave your thoughtsAuthor(s): Carolina Cuéllar-García, Mattias Mattsson, Panagiotis Baliakas, Lydia Scarfo, Eva Puy Vicente, Paolo Ghia, Richard Rosenquist, Carol Moreno Abstract:...
THERAPEUTIC DISRUPTION OF THE BAFF- B-CELL RECEPTOR (BCR) CROSS-TALK IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS
15 októbra, 2020 7:25 pm Leave your thoughtsAuthor(s): Cody Paiva, Taylor Rowland, Bhargava Sreekantham, et. al. Abstract: S 118 Session topic: 5. Chronic lymphocytic leukemia...
LIEČBA, EKONOMICKÝ A SOCIÁLNY ÚČINOK SUBKUTÁNNE PODÁVANÉHO RITUXIMABU PRI LYMFOPROLIFERATÍVNYCH MALIGNITÁCH – MAB SC
15 októbra, 2020 7:25 pm Leave your thoughtsAutor (i): Valeria Tomarchio, Maria Antonietta Surano, Maria Antonietta Tafuri, Marco Becilli, Chiara Sarlo, Pierparolo Berti, Silvia Ferraro, Rita Proietti,...
Chronická lymfocytová leukémia: novinky z kongresu
15 októbra, 2020 7:25 pm Leave your thoughtsChronická B-lymfocytová leukémia (CLL) je lymfoproliferatívna neoplázia, ktorá patrí do širokej skupiny lymfómov z B-buniek. V našej populácii je najčastejším leukemickým ochorením (tvorí...